Turnover
≈ €280,000 estimated
The micro format states no turnover.
ERNALIX Med
Lifetime
14 annual accounts with figures on one time axispeak €163,860 (2022)
€152,565▼ 6.9%
lowest -€10,848 (2016)
€43,628▼ 0.9%
peak €328,851 (2023)
€328,851▲ 15.3%
€44,192▼ 6.5%
Board1 name since 2020
1 director
Documentsfilings and deeds
02-06-2025306 days late
2023micro format
Equity from €285,223 to €328,851Cash from €20,601 to €7,338
Key points
from the 2023 annual accountsFilings
14 annual accounts 471 days past the deadline
2024 accounts not filed: deadline was 31-07-2025.
Position in the sector
88.2%
Higher solvency than 81% of companies in human health. Sector median 65.9% · 17,757 companies.
Bankruptcy probability
No current score
Figures too old
The latest figures are for FY 2023. They are too old for a current score.
Bankruptcy probability: Elevated
Filing: At least two annual filings are missing
Bankruptcy probability within 12 months
Financial strength, FY 2023
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0808336533
Incorporation
published on 18-12-2008 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ERNALIX Med Charleroi | €373,042 | €152,565 | 88.2% | - |
| DOCTEUR XAVIER LEQUEU Lessines | €415,379 | €161,369 | 92.5% | 1 |
| Dokter Caroline Burm Beveren-Kruibeke-Zwijndrecht | €376,506 | €148,084 | 90.7% | - |
| Dr. VAN GERVEN J. Rumst | €406,170 | €148,108 | 97.1% | - |
| DR. JORIS ANCIAUX Hove | €335,605 | €145,176 | 89.9% | - |
| Docteur BEN JABALLAH Verviers | €370,310 | €137,098 | 64.8% | - |
| DR THIERRY COOMANS DE BRACHENE,ALGEMENE GENEESKUNDE Wemmel | €342,862 | €138,412 | 58.1% | - |
These companies have the same main activity as ERNALIX Med: general medical practice (NACE 86210). They are comparable in size and age: total assets between €336,000 and €415,000, founded between 2008 and 2009.
Official details
Source: KBO- Status
- Active since 10-12-2008Normal situation
- Activity
- General medical practiceNACE 86210
- Financial year end
- 31 December
- Peppol
- Reachable since 07-11-2024
Insights on ERNALIX Med
ERNALIX Med files the micro format. That format states no turnover. The gross margin rose from €93,318 in 2009 to €152,565 in 2023.
The balance sheet grew most from 2010 to 2012 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ERNALIX Med
- What is the company number of ERNALIX Med?
- The company number of ERNALIX Med is 0808.336.533. The VAT number is the same number with BE in front: BE 0808.336.533.
- Where is ERNALIX Med based?
- The registered office is at Rue Isaac 6, 6000 Charleroi.Company details
- What does ERNALIX Med do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of ERNALIX Med?
- ERNALIX Med is a private limited company (pre-2019) (BVBA).
- When was ERNALIX Med founded?
- ERNALIX Med was founded on 10-12-2008.
- Is ERNALIX Med still active?
- Yes, ERNALIX Med is an active enterprise in the KBO register.
- What is the turnover of ERNALIX Med?
- The turnover in financial year 2023 is ≈ €280,000. This figure is estimated from the gross margin of €152,565 and 30 comparable companies (NACE 86210). It probably lies between €220,000 and €350,000.Financials
- Is ERNALIX Med profitable?
- In financial year 2023, ERNALIX Med made a profit of €43,628.
- Where can I find the annual accounts of ERNALIX Med?
- ERNALIX Med filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2023.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.